Navigation Links
Diagnostics Market in Transition--Amid Regulatory Uncertainty and Intensifying Competition
Date:7/15/2014

NEW YORK, July 15, 2014 /PRNewswire-iReach/ -- Venture Planning Group (www.VPGMarketResearch.com), an international publishing and management consulting firm, is pleased to introduce "Diagnostics Market in Transition--Amid Regulatory Uncertainty and Intensifying Competition," a series of new global surveys designed to identify major business opportunities emerging in the diagnostics market during the next five years.  The reports examine key trends in the U.S., five major European countries (France, Germany, Italy, Japan, UK) and Japan; review over 400 current and emerging assays; analyze potential applications of innovative diagnostic technologies; forecast volume and sales by assay, market segment, and country; provide test volume estimates by method; profile leading players and potential market entrants; and suggest alternative business expansion strategies for suppliers.

To review these new reports, please visit http://www.vpgmarketresearch.com/Diagnostics-Market-in-Transition.html

- Winning Strategies in Molecular Diagnostics 
Integrating New Technology Planning with Business and Corporate Strategies
Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence

- Infectious Disease Testing:  Rapidly Growing and Challenging Market Facing Suppliers
Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence

- Cancer Diagnostics:  Market on the Verge of Explosion
Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence    

- Immunodiagnostics: Spot Fast-Growing Market Segments
Therapeutic Drug Monitoring (TDM), Endocrine Function, Tumor Markers, Special Chemistry, Immunoproteins, Drugs of Abuse

- Hematology and Flow Cytometry: A Market Facing Regulatory and Competitive Challenges
Advances in Molecular Diagnostics, IT, and Growing Understanding of Immunologic Forces Regulating Systemic Diseases Will Profoundly Impact the Market

- Coagulation Testing in Transition
Convergence of Regulatory Uncertainty, Technological Advances, and Intensifying Competition Create Opportunities with Significant Upside

- 2014 Molecular Blood Typing, Grouping and Infectious Disease NAT Market
France, Germany, Italy, Japan, Spain, UK, US--Emerging Technologies, Sales Forecasts, Supplier Shares, Competitive Strategies

These thought-provoking reports are designed to provide the in vitro diagnostics industry executives with strategically significant competitor information, analysis and insight crucial to the development and implementation of effective business, marketing and R&D programs.

The studies offer expert analyses, strategic insights and granular data, such as supplier shares and sales forecasts for over 400 diagnostic tests by country and market segment.

The reports are available by region, country, section, market segment, individual test, and can be custom-tailored to specific information needs and budget.

The global diagnostic market is undergoing significant transformation, caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition.  Some segments, like routine chemistry, are already resembling commodity markets, where product positioning and cost per test are more critical than underlying technology.  This evolving marketplace creates exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, and calibrators.

The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances will radically change the global diagnostics market during the next five years.  New specific and sensitive markers will be increasingly used on automated instrumentation.  Diagnostic testing will also become more standardized, offering opportunities for quality control products and services.  Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the diagnostic testing closer to the patient, thus creating additional opportunities and challenges for suppliers.

To review these and related IVD reports, please visit http://www.vpgmarketresearch.com/In-Vitro-Diagnostics

For further details or questions regarding these reports, please contact:

Robert Fisher
Robert@vpgcorp.com 
+1 212 564 2838

www.VPGMarketResearch.com

www.LeadingMarketResearch.com

Media Contact: Robert Fisher, Venture Planning Group, 212-564-2838, robert@vpgcorp.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Venture Planning Group
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. QBC Diagnostics Awarded GSA Contract
2. Quest Diagnostics Establishes Unique Healthcare Identifier to Improve Access to Vital Patient Health Information; 80 Million Patient IDs Created to Date
3. Heightened Awareness, Coupled with Expanding Patient Pool, Stimulates Sleep Apnea Diagnostics and Sleep Services Market, Says Frost & Sullivan
4. Ariosa Diagnostics to Present and Exhibit at the 16th International Conference on Prenatal Diagnosis and Therapy
5. ZINO Society Targets Medical Devices, Healthcare IT and Diagnostics
6. Quest Diagnostics To Speak At The Wells Fargo Securities 2012 Healthcare Conference
7. Breakthrough Prostate Cancer Diagnostics
8. NicOx Signs Worldwide Licensing Agreement With Rapid Pathogen Screening, Inc. For Ophthalmic Diagnostics
9. Frost & Sullivan: Expanding Sample Prep Market Supports Growth Trends in Molecular Diagnostics Markets
10. QIAGEN Unveils Initiative to Create Next-Generation Sequencing Portfolio for use in Clinical Research and Molecular Diagnostics
11. Quest Diagnostics to Release Second Quarter 2012 Financial Results on July 19
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... de marzo de 2017   VWR ... soluciones de productos y servicios para clientes de ... adquirido EPL Archives, Inc., una organización de servicios ... todo el ciclo de vida de investigación de ... de archivo, almacenamiento de documentos y servicios complementarios. ...
(Date:3/22/2017)... 22, 2017 Ampio Pharmaceuticals, Inc. (NYSE ... Ampion™, a low molecular weight fraction of human ... it is re-issuing its previous release that was made ... that are required under the NYSE MKT Company ... additional disclosures along with the previously disclosed update ...
(Date:3/22/2017)... New Jersey,s hospitals ... and saved $641 million in healthcare costs between 2012 ... quality improvement program. The results reflect ... part of a national initiative from the U.S. Department ... Jersey Hospital Association and its affiliate, the Health Research ...
Breaking Medicine Technology:
(Date:3/23/2017)... ... 23, 2017 , ... Natural Subsistence, a company known for ... and nutrition, announced its product Leyzene is now available for purchase on Go4ItNutrition.com, ... that help people improve all aspects of their health so they can live ...
(Date:3/23/2017)... ... March 23, 2017 , ... The American Board of ... the 40th Anniversary of ABQAURP’s dedication to Health Care Quality and Management and Patient ... contributed not only to the association, but also to the Health Care Quality and ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... with European Guidelines and the New MEDDEV 2.7/1 Rev. 4 Guidance, **An ... http://www.fdanews.com/mdclineval                  , How will the new EU MDR language change ...
(Date:3/23/2017)... ... March 23, 2017 , ... “Beyond and Back”: a true-life testimony of tragedy ... of published author Bonetta Rose, a wife, mother and grandmother committed to sharing her ... Faith Publishing, Bonetta Rose‘s new book presents actual events in the life of her ...
(Date:3/23/2017)... ... March 23, 2017 , ... “A Respectful ... “A Respectful Response To Atheist Manifesto” is the creation of published author Richard ... Nancy, for sixty years. He holds graduate degrees from Kent State University and ...
Breaking Medicine News(10 mins):